FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Dr. Reddys Recalls Shattering Phytonadione Ampules

Dr. Reddys Laboratories recalls four lots of phytonadione injectable emulsion, 10 mg/mL single-dose ampules due to the potential for ampules to break ...

Human Drugs

Guide on Drug/Biologic Manufacturing Disruptions

FDA releases a guidance entitled Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing Under Section 506C of the FD&C Act.

Medical Devices

Guidance on CDRH Appeals Process Q & A

FDA releases a guidance entitled Center for Devices and Radiological Health (CDRH) Appeals Processes: Questions and Answers About 517A.

Human Drugs

FDA Warns Carahealth on Unapproved Virus Therapy

FDA sends Warning Letter to Carahealth (Galway, Ireland) objecting to herbal products being offered online for treating Covid-19 patients.

Federal Register

Allergenic Panel Meeting Canceled

Federal Register notice: FDA cancels a 5/15 Advisory Committee meeting due to outstanding review issues related to the safety and efficacy of DBV Tech...

Federal Register

Modified Device Consensus Standards Listing

Federal Register notice: FDA modifies the list of standards it recognizes for use in medical device premarket reviews.

Medical Devices

FAQ on 3D Printing of Medical Devices

FDA posts Frequently Asked Questions on 3D Printing of Medical Devices, Accessories, Components, and Parts During the Covid-19 Pandemic.

Human Drugs

FDA Nixes Trump Again on Chloroquine Use

Despite repeated urging from president Trump to use the malaria drug chloroquine to treat coronavirus patients, FDA reiterates that a randomized contr...

Human Drugs

FDA Ends Clinical Data Summary Pilot

CDER ends its clinical data summary pilot program.

Human Drugs

Stimulus Bill Includes New OTC Drug User Fees

The coronavirus-related economic stimulus legislation includes language to allow FDA to create a new user fee program for over-the-counter drugs.